Vortioxetine Approval Status beta

  • FDA approved: No
  • Generic name: vortioxetine
  • Company: Takeda Pharmaceutical Company Limited and H. Lundbeck A/S
  • Treatment for: Depression

Vortioxetine is a multimodal antidepressant in development for the treatment of major depressive disorder (MDD).

FDA Approval Status for vortioxetine

DateArticle
Dec 12, 2012FDA Accepts Takeda and Lundbeck's Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
Oct  1, 2012Takeda and Lundbeck Announce the U.S. Submission of a New Drug Application for Vortioxetine, an Investigational Drug for the Treatment of Major Depressive Disorder

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web6)